Navigation Links
Patient Enrollment in Urgent(R) PC SUmiT Clinical Trial Completed Ahead of Schedule
Date:1/26/2009

Study to support Urgent(R) PC clinical success and expanded reimbursement coverage

MINNEAPOLIS, Jan. 26 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (Amex: UPI) announced today the completion of patient enrollment in the randomized, controlled multicenter clinical study of its Urgent PC neuromodulation system for the treatment of overactive bladder (OAB) symptoms of urinary urgency, urge incontinence and frequency of urinary voids. A total of 214 patients have enrolled two months ahead of schedule in the clinical Study of Urgent PC vs. Sham Effectiveness in Treatment of Overactive Bladder Symptoms (SUmiT) at 22 centers throughout the United States.

The study is designed to directly compare the effectiveness of percutaneous tibial nerve stimulation (PTNS) using Urgent PC to a non-active sham. Uroplasty is undertaking this study primarily to expand and support third-party reimbursement coverage in the U.S. The study will evaluate reductions in urinary urgency, urge incontinence and frequency of urinary voids, as well as patient quality of life measures, and is expected to be completed by early fall of 2009.

"The early completion of enrollment in this trial illustrates the strong physician interest and patient acceptance of PTNS therapy at the participating centers," said Dr. Kenneth M. Peters, Chairman of the Department of Urology at Beaumont Hospital in Royal Oak, Michigan, and the SUmiT study's principal investigator. "We believe the study's design will deliver to the medical community additional key scientific data on PTNS," added Dr. Peters.

More than 33 million Americans suffer from OAB symptoms, which dramatically impact the quality of their lives. The Urgent PC system is a minimally invasive, office-based, nonsurgical PTNS device that treats these symptoms. The Company believes physicians, pat
'/>"/>

SOURCE Uroplasty, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
7. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
10. Many Heart Attack Patients Dont Get Best Emergency Treatment
11. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... EAST SETAUKET, N.Y. , Jan. 23, 2015  Lixte Biotechnology ... sites where its Phase I trial of Lixte,s lead compound, ... 5 institutions. John S. Kovach , M.D., ... trial was planned to be completed at a single site. ...
(Date:1/23/2015)... JUNCTION, N.J. , Jan. 23, 2015  CytoSorbents ... company commercializing its CytoSorb® extracorporeal cytokine adsorber to ... patients, announced the receipt of $385,642, net of ... participant of the Technology Business Tax Certificate Transfer ...
(Date:1/23/2015)... and BOSTON , January 23, 2015 ... discovery and development company, is delighted to announce that the ... awarded to Miles Congreve (Vice President of Chemistry), ... Malcolm Weir (Chief Executive Officer and co-founder) for ...
Breaking Medicine Technology:Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4
... SWIFTWATER, Pa., Oct. 21, 2011 Sanofi Pasteur, the vaccines ... ), announced today data from a new study examining the ... with the responses of elderly and younger adults to a ... the 49th Annual Meeting of the Infectious Diseases Society of ...
... Inc. ( Hologic or the Company) (Nasdaq: ... of premium diagnostic products, medical imaging systems and surgical ... today announced that it will showcase its breast tomosynthesis ... the 59th Congress of the Journees Francaises de Radiologie ...
Cached Medicine Technology:Sanofi Pasteur Presents New Data Confirming Fluzone® High-Dose (Influenza Virus Vaccine) Produces Higher Antibody Response in the Age 65+ Population 2Sanofi Pasteur Presents New Data Confirming Fluzone® High-Dose (Influenza Virus Vaccine) Produces Higher Antibody Response in the Age 65+ Population 3Sanofi Pasteur Presents New Data Confirming Fluzone® High-Dose (Influenza Virus Vaccine) Produces Higher Antibody Response in the Age 65+ Population 4Sanofi Pasteur Presents New Data Confirming Fluzone® High-Dose (Influenza Virus Vaccine) Produces Higher Antibody Response in the Age 65+ Population 5Sanofi Pasteur Presents New Data Confirming Fluzone® High-Dose (Influenza Virus Vaccine) Produces Higher Antibody Response in the Age 65+ Population 6Hologic to Host Special Tomosynthesis Symposium and Feature the Latest in Women's Health Technologies at the Journees Francaises de Radiologie (JFR) 2Hologic to Host Special Tomosynthesis Symposium and Feature the Latest in Women's Health Technologies at the Journees Francaises de Radiologie (JFR) 3Hologic to Host Special Tomosynthesis Symposium and Feature the Latest in Women's Health Technologies at the Journees Francaises de Radiologie (JFR) 4Hologic to Host Special Tomosynthesis Symposium and Feature the Latest in Women's Health Technologies at the Journees Francaises de Radiologie (JFR) 5
(Date:1/22/2015)... A new white paper by The Beryl ... the long-term care environment as well as provides recommendations ... paper, “The Power of Person-Centeredness in Long-Term Care: A ... the patient, resident and family experience in long-term care ...
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post explaining the ... . , Auto insurance quotes help many drivers find ... necessary to call an agent or visit an agency for ... single website: http://autocarinsurancebest.com/ . , Every business who relies ...
(Date:1/22/2015)... Carinsurancesavings.biz has released a new blog post presenting the ... , Purchasing an accidental death and dismemberment rider for ... of rider provides benefits if the insured dies in an ... form of life insurance. , AD&D is not expensive ...
(Date:1/22/2015)... NY (PRWEB) January 22, 2015 ... of Sports Medicine flagship journal Medicine & Science ... L-Citrulline before exercise may help reduce gastrointestinal (GI) ... 1 , Participants in the double-blind, placebo-controlled ...
(Date:1/22/2015)... Recently, Weddingshe.com has added many trendy Champagne ... highest annual revenues in the past three years. Today, the ... dresses. , According to the sales manager of the company, ... them in 2015. This point can be reflected on the ...
Breaking Medicine News(10 mins):Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2
... Liverpool have found that the strength of uterine contractions in ... increasing the risk of emergency caesarean birth. ... by diabetes has increased by approximately 50%. There has, ... a quarter will have a normal vaginal delivery. ...
... body is undeniable. However, the idea of what makes a ... A new study from the Journal of Agriculture and ... determining the quality of a protein. Traditional methods for ... eggs to be high in quality. However, those who are interested ...
... of cells in the artery begins to regrow. In the ... Maria Gomez. A common cause of arterial injuries is ... have had a heart attack. "Initially the artery is ... the risk of further heart attacks." In animal experiments, ...
... increased by a record 5.9 per cent in 2010 ... Crisis (GFC), according to scientists working with the Global ... its annual analysis in the journal Nature Climate ... on emissions has been short-lived owing to strong emissions ...
... HealthDay Reporter , MONDAY, Dec. 5 (HealthDay News) -- A ... than his body weight, a novel finding that runs counter to ... the journal Circulation finds that improving or even just ... whether your body weight has stayed the same or even gone ...
... initiative improved employees, health behavior and well-being, including a rise ... management, according to a new study by University of Minnesota ... the December issue of the Journal of Health and ... from viewing time at the office as a sign of ...
Cached Medicine News:Health News:Poorly contracting uterus in diabetic women increases risk of caesarean birth 2Health News:Soy is on top as a high-quality plant protein 2Health News:Stopping dangerous cell regrowth reduces risk of further heart attacks 2Health News:Global Carbon Project annual emissions summary 2Health News:Fitness May Lower Death Risk Even Without Weight Loss 2Health News:Fitness May Lower Death Risk Even Without Weight Loss 3Health News:Study suggests flexible workplaces promote better health behavior and well-being 2
Inquire...
Nature's Remarkable Skin Protector -- Karaya 5 is a natural skin barrier that is particularly well suited for skin problems or for sensitive skin where reactions may have occurred to other types of s...
Superior Skin Care...FlexWear skin barrier provides skin protection for an extended wear time....
Inquire...
Medicine Products: